Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance, Oncol Rep, vol.27, issue.6, pp.1779-1786, 2012. ,
Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2, Cancer Biol Ther, vol.11, issue.7, pp.678-689, 2011. ,
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?, Ann Oncol, vol.26, issue.9, pp.1813-1823, 2015. ,
,
A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens, Immunity, vol.40, issue.1, p.30742, 2012. ,
Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription, J Immunol, vol.178, issue.12, pp.7632-7639, 2007. ,
Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses, Cell Death Dis, vol.6, p.1828, 2015. ,
CD39 and CD161 modulate Th17 responses in Crohn's disease, J Immunol, vol.193, issue.7, pp.3366-3377, 2014. ,
Structure and catalytic function of sphingosine kinases: analysis by site-directed mutagenesis and enzyme kinetics, Biochim Biophys Acta, vol.1831, issue.1, pp.139-146, 2013. ,
Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade, Histopathology, vol.58, issue.7, pp.22328-22337, 2010. ,
Sphingosine Kinases promote IL-17 expression in human T lymphocytes, Sci Rep, vol.8, issue.1, p.13233, 2018. ,
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse, J Clin Oncol, vol.24, issue.34, pp.5373-5380, 2006. ,
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis, J Clin Invest, vol.122, issue.6, pp.2066-2078, 2012. ,
Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver, J Biol Chem, vol.285, issue.14, pp.10880-10889, 2010. ,
T cell-intrinsic S1PR1 regulates endogenous effector T-cell egress dynamics from lymph nodes during infection, Proc Natl Acad Sci U S A, vol.113, issue.8, pp.2182-2187, 2016. ,
Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor, Eur J Immunol, vol.43, issue.6, pp.1518-1528, 2013. ,
Lysosomal sphingomyelinase is not solicited for apoptosis signaling, FASEB J, vol.15, issue.2, pp.297-299, 2001. ,
Regulation of sphingomyelin metabolism, Pharmacol Rep, vol.68, issue.3, pp.570-581, 2016. ,
,
, Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 -Tumeurs solides. Saint-Maurice (Fra), J Lipid Res, vol.55, issue.8, pp.1596-1608, 2014.
Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFkappaB binding to ST8SIA1 promoter, PLoS One, vol.8, issue.4, p.62559, 2013. ,
Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate, J Cell Biochem, vol.109, issue.6, pp.1232-1243, 2010. ,
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1), Ann Oncol, vol.27, issue.5, pp.812-818, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01791274
Ceramide kinase: the first decade, Cell Signal, vol.23, issue.6, pp.999-1008, 2011. ,
The Neutral Sphingomyelinase 2 Is Required to Polarize and Sustain T Cell Receptor Signaling, Front Immunol, vol.9, p.815, 2018. ,
Molecular cloning and characterization of the mouse CGT gene encoding UDP-galactose ceramide-galactosyltransferase (cerebroside synthetase), Genomics, vol.35, issue.1, pp.223-226, 1996. ,
CD28 signals through acidic sphingomyelinase, J Exp Med, vol.181, issue.6, pp.2059-2068, 1995. ,
Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients, Curr Protoc Hum Genet, vol.90, pp.23-34, 2016. ,
,
Lipid phosphate phosphatase 3 enables efficient thymic egress, J Exp Med, vol.208, issue.6, pp.1267-1278, 2011. ,
Immunological surveillance in neoplasia, Transplant Rev, vol.7, pp.3-25, 1971. ,
Cancer; a biological approach. I. The processes of control, Br Med J, vol.1, issue.5022, pp.779-786, 1957. ,
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer, Clin Cancer Res, vol.21, issue.7, pp.129-131, 1996. ,
ORMDL proteins regulate ceramide levels during sterile inflammation, J Lipid Res, vol.57, issue.8, pp.1412-1422, 2016. ,
,
Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-alphaVbeta5 axis, J Exp Med, vol.215, issue.6, pp.1679-1692, 2018. ,
Kruppel-like factor 2 regulates thymocyte and T-cell migration, Nature, vol.442, issue.7100, pp.299-302, 2006. ,
GD(3) synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation, Mol Cancer Res, vol.8, issue.11, pp.1526-1535, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00523434
Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference, J Clin Invest, vol.114, issue.8, pp.1082-1089, 2004. ,
Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species, Exp Mol Pathol, vol.82, issue.1, pp.1-11, 2007. ,
Metabolism of shortchain ceramide by human cancer cells--implications for therapeutic approaches, Biochem Pharmacol, vol.80, issue.3, pp.308-315, 2010. ,
, , 2001.
, Taxol-induced ceramide generation and apoptosis in human breast cancer cells, Cancer Chemother Pharmacol, vol.47, issue.5, pp.444-450
Increased ceramide production sensitizes breast cancer cell response to chemotherapy, Cancer Chemother Pharmacol, vol.79, issue.5, pp.933-941, 2017. ,
,
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype, Clin Cancer Res, vol.14, issue.5, pp.1368-1376, 2008. ,
Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor, Histopathology, vol.63, issue.2, pp.225-233, 2013. ,
Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus, Cell Mol Immunol, vol.3, issue.1, pp.11-19, 2006. ,
TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx, J Leukoc Biol, vol.148, issue.5, pp.266-278, 2005. ,
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase, J Exp Med, vol.180, issue.4, pp.1547-1552, 1994. ,
Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-alpha in MCF-7 cells, Biochem J, vol.435, issue.2, pp.381-390, 2011. ,
Ceramidases, roles in sphingolipid metabolism and in health and disease, Adv Biol Regul, vol.63, pp.122-131, 2017. ,
CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase, J Biol Chem, vol.273, issue.13, pp.7560-7565, 1998. ,
The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus), Proc R Soc Med, vol.3, pp.1-48, 1910. ,
The Activity of the Neutral Sphingomyelinase Is Important in T Cell Recruitment and Directional Migration, Front Immunol, vol.8, p.1007, 2017. ,
, Bull Cancer, vol.66, issue.1, pp.1-8, 1979.
Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes, Biophys J, vol.88, issue.1, pp.348-359, 2005. ,
Regulation of human EGF receptor by lipids, Proc Natl Acad Sci U S A, vol.108, issue.22, pp.9044-9048, 2011. ,
Ceramide enables fas to cap and kill, J Biol Chem, vol.276, issue.26, pp.23954-23961, 2001. ,
Tumor-associated antigens in breast cancer, Breast Care (Basel), vol.7, issue.4, pp.262-266, 2012. ,
Confounding effects in "A six-gene signature predicting breast cancer lung metastasis, Cancer Res, vol.69, issue.18, pp.7480-7485, 2009. ,
, De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer, vol.28, pp.1700-1712, 2017.
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate, Nature, vol.381, issue.6585, pp.800-803, 1996. ,
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide, Nature, vol.449, issue.7158, pp.62-67, 2007. ,
SPHK1 regulates proliferation and survival responses in triple-negative breast cancer, Oncotarget, vol.5, issue.15, pp.5920-5933, 2014. ,
,
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer, Breast Cancer Res, vol.17, p.71, 2015. ,
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, vol.16, issue.2, pp.91-102, 2009. ,
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy, Cancer Discov, vol.1, issue.1, pp.54-67, 2011. ,
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer, J Clin Oncol, vol.28, issue.1, pp.105-113, 2010. ,
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy, Lancet Oncol, vol.19, issue.1, pp.40-50, 2018. ,
, Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group, vol.29, pp.1155-1164, 2016.
Death or survival: membrane ceramide controls the fate and activation of antigen-specific T-cells depending on signal strength and duration, Cell Signal, vol.18, issue.3, pp.294-306, 2006. ,
Prognostic value of tumorinfiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study, Ann Oncol, vol.26, issue.7, p.1518, 2015. ,
Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials, Ann Oncol, vol.26, issue.8, pp.1698-1704, 2015. ,
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study, Breast Cancer Res Treat, vol.167, issue.3, pp.671-686, 2018. ,
Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast, Am J Transl Res, vol.9, issue.12, pp.5684-5695, 2017. ,
Re-configuration of sphingolipid metabolism by oncogenic transformation, Biomolecules, vol.4, issue.1, pp.315-353, 2014. ,
CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice, Int Immunol, vol.24, issue.5, pp.327-337, 2012. ,
Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases, FASEB J, vol.29, issue.12, pp.5018-5028, 2015. ,
Human Naive and Memory T Cells Display Opposite Migratory Responses to Sphingosine-1 Phosphate, J Immunol, vol.200, issue.2, pp.551-557, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01911329
S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice, Cancer Res, vol.70, issue.2, pp.772-781, 2010. ,
TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis, Oncogene, vol.25, issue.41, pp.5612-5625, 2006. ,
The three Es of cancer immunoediting, Annu Rev Immunol, vol.22, pp.329-360, 2004. ,
Sphingomyelin organization is required for vesicle biogenesis at the Golgi complex, EMBO J, vol.31, issue.24, pp.4535-4546, 2012. ,
Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases, Br J Cancer, vol.103, issue.4, pp.524-531, 2010. ,
Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility, Oncogene, vol.34, issue.8, pp.996-1005, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01063558
, S1P1 deletion differentially affects TH17 and Regulatory T cells, vol.7, 2017.
Sunitinib and SU11652 inhibit acid sphingomyelinase, destabilize lysosomes, and inhibit multidrug resistance, Mol Cancer Ther, vol.12, issue.10, pp.2018-2030, 2013. ,
Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression, Biochem Biophys Res Commun, vol.13, issue.5, pp.219-223, 2010. ,
The importance of stromal and intratumoral tumor lymphocyte infiltration for pathologic complete response in patients with locally advanced breast cancer, HER2-positive breast cancer: Current and new therapeutic strategies, vol.14, pp.80-88, 2018. ,
Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics, Oncoimmunology, vol.5, issue.12, p.1248015, 2016. ,
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial, Semin Diagn Pathol, vol.23, issue.14, pp.193-198, 1994. ,
Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel, Int J Mol Sci, vol.15, issue.3, pp.4201-4220, 2014. ,
Elovl6 is a poor prognostic predictor in breast cancer, Oncol Lett, vol.12, issue.1, pp.207-212, 2016. ,
Regulation of very-long acyl chain ceramide synthesis by acyl-CoA-binding protein, J Biol Chem, vol.292, issue.18, pp.7588-7597, 2017. ,
Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation, Biochim Biophys Acta, vol.1861, issue.11, pp.1840-1851, 2016. ,
C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth, Breast Cancer Res Treat, vol.133, issue.2, pp.447-458, 2012. ,
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res, vol.13, issue.12, pp.835-837, 1953. ,
The immune contexture in human tumours: impact on clinical outcome, Nat Rev Cancer, vol.12, issue.4, pp.298-306, 2012. ,
Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model, Breast Cancer Res Treat, vol.120, issue.2, pp.379-389, 2010. ,
Sphingosine 1-phosphate increases an intracellular Ca(2+) concentration via S1P3 receptor in cultured vascular smooth muscle cells, J Pharm Pharmacol, vol.66, issue.6, pp.802-810, 2014. ,
The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice, J Clin Invest, vol.122, issue.4, pp.1416-1426, 2012. ,
Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast, J Cell Biol, vol.155, issue.6, pp.949-959, 2001. ,
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2, Proc Natl Acad Sci, vol.5, issue.8, pp.777-782, 2004. ,
Dihydroceramide delays cell cycle G1/S transition via activation of ER stress and induction of autophagy, Int J Biochem Cell Biol, vol.44, issue.12, pp.2135-2143, 2012. ,
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents, Cancer Cell, vol.28, issue.6, pp.690-714, 2015. ,
Immunogenic cell death in cancer and infectious disease, Nat Rev Immunol, vol.17, issue.2, pp.97-111, 2017. ,
A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes, J Vis Exp, vol.94, 2014. ,
Cholesterol interactions with ceramide and sphingomyelin, Chem Phys Lipids, vol.199, pp.26-34, 2016. ,
GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade, Mol Ther, vol.24, issue.6, pp.1135-1149, 2016. ,
Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond, Immunology, vol.142, issue.3, pp.347-353, 2014. ,
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation, Nat Immunol, vol.14, issue.11, pp.1166-1172, 2013. ,
Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer, Cancer Immunol Res, vol.5, issue.12, pp.1086-1097, 2017. ,
Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes, Cancer Res, vol.75, issue.14, pp.2775-2787, 2015. ,
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual, CA Cancer J Clin, vol.67, issue.4, pp.290-303, 2017. ,
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome, Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, vol.69, pp.1736-1747, 2009. ,
Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4, FASEB J, vol.24, issue.12, pp.4701-4710, 2010. ,
Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs, Cancer Res, vol.65, issue.9, pp.3861-3867, 2005. ,
EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue, Genomics, vol.53, issue.2, pp.164-169, 1998. ,
The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13, J Cell Biochem, vol.89, issue.3, pp.507-519, 2003. ,
Ceramide-rich membrane rafts mediate CD40 clustering, J Immunol, vol.168, issue.1, pp.298-307, 2002. ,
Sphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammation, PLoS One, vol.7, issue.5, p.36475, 2012. ,
Intradermal Immunization of C3H Mice against a Sarcoma That Originated in an Animal of the Same Line, Cancer Research, vol.3, issue.5, pp.326-333, 1943. ,
Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer, Chembiochem, vol.18, issue.13, pp.1146-1154, 2017. ,
CD4(+) follicular helper T cell infiltration predicts breast cancer survival, J Clin Invest, vol.123, issue.7, pp.2873-2892, 2013. ,
The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice, Prog Lipid Res, vol.49, issue.2, pp.186-199, 2010. ,
Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate, Science, vol.325, issue.5945, pp.1254-1257, 2009. ,
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERalpha expression and enhances hormonal therapy for breast cancer, 2015. ,
Role of sphingosine kinase 2 in cell migration toward epidermal growth factor, J Biol Chem, vol.280, issue.33, pp.29462-29469, 2005. ,
Molecular machinery for non-vesicular trafficking of ceramide, Nature, vol.426, issue.6968, pp.803-809, 2003. ,
Crystal structure of a lipid G protein-coupled receptor, Science, vol.335, issue.6070, pp.851-855, 2012. ,
In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody, PLoS One, vol.7, issue.4, p.35129, 2012. ,
Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth, Int J Biochem Cell Biol, vol.44, issue.4, pp.620-628, 2010. ,
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial, JAMA Oncol, vol.1, issue.8, pp.1087-1095, 2015. ,
Ceramide Synthase 6 Deficiency Enhances Inflammation in the DSS model of Colitis, Sci Rep, vol.8, issue.1, p.1627, 2018. ,
Epigenetic control of CD8(+) T cell differentiation, Nat Rev Immunol, vol.18, issue.5, pp.340-356, 2018. ,
The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis, J Immunother, vol.28, issue.4, pp.343-351, 2005. ,
,
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization, Autophagy, vol.12, issue.11, pp.2213-2229, 2016. ,
Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes, Nat Immunol, vol.10, issue.7, pp.761-768, 2009. ,
T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion, Cancer Res, vol.72, issue.21, pp.5473-5482, 2012. ,
Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation, Nat Commun, vol.5, p.4806, 2014. ,
Inhibition of Acid Sphingomyelinase Allows for Selective Targeting of CD4+ Conventional versus Foxp3+ Regulatory T Cells, J Immunol, vol.197, issue.8, pp.3130-3141, 2016. ,
Molecular cloning and expression of cDNA encoding human 3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase, J Biol Chem, vol.272, issue.8, pp.4864-4868, 1997. ,
The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases, J Biol Chem, vol.284, issue.39, pp.26322-26330, 2009. ,
Identification of a family of animal sphingomyelin synthases, EMBO J, vol.23, issue.1, pp.33-44, 2004. ,
Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial, Proc Natl Acad Sci U S A, vol.4, issue.7, pp.4638-4643, 1996. ,
Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor, Biochem Biophys Res Commun, vol.346, issue.1, pp.293-300, 2006. ,
Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin, Biochim Biophys Acta, vol.1789, p.1627, 2009. ,
Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival, J Neurosci, vol.25, issue.6, pp.1459-1469, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01936307
Role for ceramide in cell cycle arrest, J Biol Chem, vol.270, issue.5, pp.2047-2052, 1995. ,
Loss of ceramide synthase 3 causes lethal skin barrier disruption, Hum Mol Genet, vol.21, issue.3, pp.586-608, 2012. ,
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer, Breast Cancer Res Treat, vol.131, issue.3, pp.765-775, 2012. ,
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response, Breast Cancer Res, vol.17, p.43, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01820311
Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation, Blood, vol.101, issue.12, pp.4909-4915, 2003. ,
Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells, Int Immunol, vol.20, issue.11, pp.1427-1437, 2008. ,
PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA), J Biol Chem, vol.277, issue.38, pp.35257-35262, 2002. ,
Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer, J Immunol Res, vol.9, issue.434, p.4757405, 2016. ,
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer, J Surg Res, vol.219, pp.202-213, 2017. ,
The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors, Science, vol.323, issue.5913, pp.524-527, 2009. ,
Prognostic Significance of Stromal Versus Intratumoral Infiltrating Lymphocytes in Different Subtypes of Breast Cancer Treated With Cytotoxic Neoadjuvant Chemotherapy, Appl Immunohistochem Mol Morphol, vol.26, issue.8, pp.523-532, 2018. ,
FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site that faces the cytosolic side of the endoplasmic reticulum membrane, J Biol Chem, vol.279, issue.47, pp.49243-49250, 2004. ,
Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Galphaq coupling, J Cell Sci, vol.124, pp.2220-2230, 2011. ,
C16ceramide and sphingosine 1phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation, Oncol Rep, vol.40, issue.5, pp.2977-2987, 2018. ,
Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation, J Biol Chem, vol.284, pp.12972-12978, 2009. ,
Extracellular Matrix Rigidity-dependent Sphingosine-1-phosphate Secretion Regulates Metastatic Cancer Cell Invasion and Adhesion, Sci Rep, vol.6, p.21564, 2016. ,
Sphingosine 1-phosphate promotes cell migration through the activation of Cdc42 in Edg-6/S1P4-expressing cells, Genes Cells, vol.8, issue.8, pp.685-697, 2003. ,
Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids, Annu Rev Cell Dev Biol, vol.21, pp.81-103, 2005. ,
Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas, J Biol Chem, vol.279, issue.43, pp.44311-44319, 2004. ,
C6-ceramide enhances Interleukin-12-mediated T helper type 1 cell responses through a cyclooxygenase-2-dependent pathway, Immunobiology, vol.217, issue.6, pp.601-609, 2012. ,
C6-ceramide in combination with transforming growth factor-beta enhances Treg cell differentiation and stable FoxP3 expression in vitro and in vivo, Immunobiology, vol.218, issue.7, pp.952-959, 2013. ,
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells, Clin Cancer Res, vol.14, issue.8, pp.2413-2420, 2008. ,
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival, Br J Cancer, vol.105, issue.3, pp.366-371, 2011. ,
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy, Breast Cancer Res Treat, vol.125, issue.1, pp.65-72, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00554998
Ordering of ceramide formation and caspase-9 activation in CD95L-induced Jurkat leukemia T cell apoptosis, Biochim Biophys Acta, vol.1821, issue.4, pp.684-693, 2012. ,
,
Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death, Cell Death Differ, vol.17, issue.4, pp.642-654, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00473914
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization, Cancer Res, vol.66, issue.1, pp.221-231, 2006. ,
Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate, J Biol Chem, vol.283, issue.9, pp.5677-5684, 2008. ,
Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis, J Cell Biol, vol.158, issue.6, pp.1039-1049, 2002. ,
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors, Nat Med, vol.16, issue.12, pp.1421-1428, 2010. ,
The transcription factor KLF2 restrains CD4(+) T follicular helper cell differentiation, Immunity, vol.42, issue.2, pp.252-264, 2015. ,
Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1, Science, vol.279, issue.5356, pp.1552-1555, 1998. ,
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J Clin Invest, vol.121, issue.7, pp.2750-2767, 2011. ,
,
Survival benefit of sphingosin-1-phosphate and receptors expressions in breast cancer patients, Cancer Med, vol.7, issue.8, pp.3743-3754, 2018. ,
The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration, Cancer Res, vol.65, issue.9, pp.3788-3795, 2005. ,
Mammalian ceramide synthases, IUBMB Life, vol.62, issue.5, pp.347-356, 2010. ,
Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates, FASEB J, vol.32, issue.6, pp.3058-3069, 2018. ,
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice, Gastroenterology, vol.154, issue.4, pp.1024-1036, 2018. ,
The value of detection of S100A8 and ASAH1 in predicting the chemotherapy response for breast cancer patients, Hum Pathol, vol.74, pp.156-163, 2018. ,
Alkaline ceramidase 1 is essential for mammalian skin homeostasis and regulating whole-body energy expenditure, J Pathol, vol.239, issue.3, pp.374-383, 2016. ,
Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells, Proc Natl Acad Sci U S A, vol.110, issue.13, pp.4968-4973, 2013. ,
Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype, Oncotarget, vol.8, issue.29, pp.47454-47473, 2017. ,
CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes, Breast Cancer Res Treat, vol.130, issue.2, pp.645-655, 2011. ,
The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR, Nat Immunol, vol.10, issue.7, pp.769-777, 2009. ,
The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells, Nat Immunol, vol.11, issue.11, pp.1047-1056, 2010. ,
Expression of glucosylceramide synthase in invasive ductal breast cancer may be correlated with high estrogen receptor status and low HER-2 status, Diagn Pathol, vol.9, p.22, 2014. ,
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer, Breast Cancer Res, vol.14, issue.2, p.48, 2012. ,
,
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation, J Clin Invest, vol.106, issue.8, pp.951-961, 2000. ,
Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells, J Biol Chem, vol.274, issue.2, pp.1140-1146, 1999. ,
Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance, J Biol Chem, vol.275, issue.10, pp.7138-7143, 2000. ,
,
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98, J Clin Oncol, vol.31, issue.7, pp.860-867, 2013. ,
Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells, Mol Cell Biol, vol.30, issue.15, pp.3827-3841, 2010. ,
Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells, J Biol Chem, vol.285, pp.35957-35966, 2010. ,
Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 Function during T Cell Transmigration across Brain Endothelial Cells, J Immunol, vol.196, issue.1, pp.72-79, 2016. ,
Surface tension induced by sphingomyelin to ceramide conversion in lipid membranes, Biochim Biophys Acta, vol.1768, issue.3, pp.553-561, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00169686
Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics, Int J Oncol, vol.15, issue.3, pp.541-546, 1999. ,
Structure and organization of the human galactocerebrosidase (GALC) gene, Genomics, vol.26, issue.2, pp.407-409, 1995. ,
Sphingolipid metabolites in inflammatory disease, Nature, vol.510, issue.7503, pp.58-67, 2014. ,
Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention, J Immunol, vol.194, issue.5, pp.2059-2063, 2015. ,
Cancer stem cells: impact, heterogeneity, and uncertainty, Cancer Cell, vol.21, issue.3, pp.283-296, 2012. ,
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer, J Clin Oncol, vol.29, issue.15, pp.1949-1955, 2011. ,
Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope, J Biol Chem, vol.273, issue.28, pp.17763-17770, 1998. ,
Gangliosides expressed in human breast cancer, Cancer Res, vol.56, issue.22, pp.5165-5171, 1996. ,
Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade, Mol Cancer Ther, vol.13, issue.2, pp.316-328, 2014. ,
Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity, J Biol Chem, vol.284, issue.38, pp.25542-25552, 2009. ,
Human solid tumors contain high endothelial venules: association with Tand B-lymphocyte infiltration and favorable prognosis in breast cancer, Cancer Res, vol.71, issue.17, pp.5678-5687, 2011. ,
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro, Cancer Biol Ther, vol.15, issue.6, pp.797-805, 2014. ,
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1, Nature, vol.427, issue.6972, pp.355-360, 2004. ,
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis, Neurology, vol.71, issue.16, pp.1261-1267, 2008. ,
The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate, Cell Rep, vol.2, issue.5, pp.1104-1110, 2012. ,
,
Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells, Nature, vol.546, issue.7656, pp.158-161, 2017. ,
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence, Oncotarget, vol.7, issue.40, pp.66192-66201, 2016. ,
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence, Ann Oncol, vol.27, issue.7, pp.1241-1248, 2016. ,
Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis, J Exp Med, vol.202, issue.2, pp.249-259, 2005. ,
Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer, J Transl Med, vol.14, issue.1, p.227, 2016. ,
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study, Breast Cancer Res, vol.17, p.124, 2015. ,
Essential role for sphingosine kinases in neural and vascular development, Mol Cell Biol, vol.25, issue.24, pp.11113-11121, 2005. ,
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer, Int J Cancer, vol.122, issue.10, pp.2286-2293, 2008. ,
Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation, FEBS Lett, vol.563, issue.1-3, pp.93-97, 2004. ,
,
Sustained antigen-specific antitumor recall response mediated by genemodified CD4+ T helper-1 and CD8+ T cells, Cancer Res, vol.67, issue.23, pp.11428-11437, 2007. ,
Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer, Mol Cancer Ther, vol.11, issue.11, pp.2352-2361, 2012. ,
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2, Mol Ther, vol.18, issue.4, pp.843-851, 2010. ,
Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers, J Exp Med, vol.211, issue.7, pp.1297-1305, 2014. ,
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness, Oncotarget, vol.9, issue.28, pp.19874-19890, 2018. ,
Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma, Oncotarget, vol.7, issue.44, pp.71873-71886, 2016. ,
Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients, Hum Vaccin, vol.6, issue.9, 2010. ,
Validation of Intratumoral T-bet+ Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer, Cancer Immunol Res, vol.4, issue.1, pp.41-48, 2015. ,
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis, Clin Cancer Res, vol.19, issue.2, pp.726-735, 2012. ,
High levels of sphingolipids in human breast cancer, J Surg Res, vol.204, issue.2, pp.435-444, 2016. ,
Sphingosine-1-phosphate in the lymphatic fluid determined by novel methods, Heliyon, vol.2, issue.12, p.219, 2016. ,
,
Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods, J Mammary Gland Biol Neoplasia, vol.21, issue.1-2, pp.9-17, 2016. ,
Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway, Oncogene, vol.21, issue.3, pp.337-346, 2002. ,
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study, J Clin Oncol, vol.34, issue.21, pp.2460-2467, 2016. ,
, , 2016.
, Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node, PLoS One, vol.11, issue.5, p.155347
An oncogenic role for sphingosine kinase 2, Oncotarget, vol.7, issue.40, pp.64886-64899, 2016. ,
Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5, J Lipid Res, vol.59, issue.7, pp.1219-1229, 2018. ,
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy, Exp Cell Res, vol.333, issue.2, pp.195-200, 2015. ,
,
The role of sphingosine-1-phosphate transporter Spns2 in immune system function, J Immunol, vol.189, issue.1, pp.102-111, 2012. ,
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3, J Clin Invest, vol.113, issue.4, pp.569-581, 2004. ,
Glycosphingolipid composition of MDA-MB-231 and MCF-7 human breast cancer cell lines, Breast Cancer Res Treat, vol.48, issue.2, pp.149-157, 1998. ,
Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration, FASEB J, vol.21, issue.7, pp.1503-1514, 2007. ,
Lack of costimulation by both sphingomyelinase and C2 ceramide in resting human T cells, Immunology, vol.100, issue.2, pp.225-230, 2000. ,
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptorpositive metastatic breast cancer, Ann Oncol, vol.27, pp.106-113, 2016. ,
The structure and function of the S1P1 receptor, Trends Pharmacol Sci, vol.34, issue.7, pp.401-412, 2013. ,
Programmed cell death induced by ceramide, Science, vol.259, issue.5102, pp.1769-1771, 1993. ,
Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients, Breast Cancer Res Treat, vol.136, issue.1, pp.107-116, 2012. ,
Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2, J Biol Chem, vol.278, issue.2, pp.1268-1272, 2003. ,
Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide, J Biol Chem, vol.277, issue.15, pp.12960-12969, 2002. ,
ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis, Proc Natl Acad Sci U S A, vol.107, issue.43, pp.18439-18444, 2010. ,
,
Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer, Int J Cancer, vol.132, issue.3, pp.605-616, 2012. ,
Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer, Br J Cancer, vol.106, issue.8, pp.1453-1459, 2012. ,
EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition, J Biol Chem, vol.273, issue.42, pp.27104-27110, 1998. ,
Persistence of tumorinfiltrating CD8 T cells is tumor-dependent but antigen-independent, Cell Mol Immunol, vol.8, issue.5, pp.415-423, 2011. ,
Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice, J Clin Invest, vol.121, issue.6, pp.2290-2300, 2011. ,
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor, J Biol Chem, vol.282, issue.12, pp.9082-9089, 2007. ,
GD2 expression in breast cancer, Oncotarget, vol.8, pp.31592-31600, 2017. ,
Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide, Oncotarget, vol.8, issue.44, pp.76921-76934, 2017. ,
Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule, N Engl J Med, vol.8, issue.12, pp.1836-1846, 2013. ,
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate, Science, vol.316, issue.5822, pp.295-298, 2007. ,
Ceramide kinase promotes tumor cell survival and mammary tumor recurrence, Cancer Res, vol.74, issue.21, pp.6352-6363, 2014. ,
Short-chain glycoceramides promote intracellular mitoxantrone delivery from novel nanoliposomes into breast cancer cells, Pharm Res, vol.32, issue.4, pp.1354-1367, 2015. ,
Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain sphingolipids, Pharm Res, vol.30, issue.7, pp.1883-1895, 2013. ,
S1P: the elixir of life for naive T cells, Cell Mol Immunol, vol.15, issue.7, pp.657-659, 2018. ,
Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000. ,
Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning, J Exp Med, vol.207, issue.1, pp.17-27, 2010. ,
S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress, Immunity, vol.28, issue.1, pp.122-133, 2008. ,
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation, EMBO J, vol.22, issue.20, pp.5491-5500, 2003. ,
,
CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice, Immunity, vol.45, issue.1, pp.209-223, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01359568
Checkpoint inhibitors in breast cancer -Current status, Cancer Treat Rev, vol.63, pp.122-134, 2018. ,
3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemoresistant cancer cells, Bioorg Med Chem, vol.22, issue.4, pp.1412-1420, 2014. ,
Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis, EMBO Mol Med, vol.4, issue.8, pp.761-775, 2012. ,
Glycan-related gene expression signatures in breast cancer subtypes; relation to survival, Mol Oncol, vol.9, issue.4, pp.861-876, 2015. ,
S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3, Cell Rep, vol.6, issue.6, pp.992-999, 2014. ,
SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis, Science, vol.328, issue.5983, pp.1290-1294, 2010. ,
Unbiased Lipidomic Profiling of Triple-Negative Breast Cancer Tissues Reveals the Association of Sphingomyelin Levels with Patient Disease-Free Survival, Metabolites, vol.8, issue.3, 2018. ,
Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases, Clin Cancer Res, vol.22, issue.9, pp.2859-2867, 1995. ,
Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1, Cancer Immunol Immunother, vol.66, issue.5, pp.593-603, 2017. ,
Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery, J Allergy Clin Immunol, vol.138, issue.2, pp.551-557, 2016. ,
Big bang theory of stem-like T cells confirmed, Blood, vol.124, issue.4, pp.476-477, 2014. ,
Sphingosine kinase activity is not required for tumor cell viability, PLoS One, vol.8, issue.7, p.68328, 2013. ,
Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice, Eur J Immunol, vol.47, issue.4, pp.677-684, 2017. ,
The alliance of sphingosine-1-phosphate and its receptors in immunity, Nat Rev Immunol, vol.8, issue.10, pp.753-763, 2008. ,
Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism, Mol Cancer Ther, vol.6, issue.10, pp.2777-2785, 2007. ,
Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer, Climacteric, vol.12, issue.6, pp.502-513, 2009. ,
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer, J Cancer Res Clin Oncol, vol.135, issue.1, pp.81-90, 2009. ,
,
Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer, J Cancer Res Clin Oncol, vol.135, issue.8, pp.1005-1013, 2009. ,
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer, Breast Cancer Res Treat, vol.112, issue.1, pp.41-52, 2008. ,
Leukocyte composition of human breast cancer, Proc Natl Acad Sci U S A, vol.109, issue.8, pp.2796-2801, 2012. ,
Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer, Clin Cancer Res, vol.24, issue.12, pp.2804-2811, 2018. ,
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group, Ann Oncol, vol.26, issue.2, pp.259-271, 2014. ,
Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer, Mol Oncol, vol.9, issue.1, pp.58-67, 2015. ,
Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin, Cancer Res, vol.67, issue.21, pp.10466-10474, 2007. ,
A New Gene Expression Signature for Triple Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy, Mol Med, vol.23, pp.101-111, 2017. ,
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype, Cancer Res, vol.68, issue.4, pp.989-997, 2008. ,
Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region, J Biol Chem, vol.291, issue.14, pp.7477-7487, 2016. ,
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis, Nat Med, vol.24, issue.7, pp.986-993, 2018. ,
Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1, J Biol Chem, vol.279, issue.18, pp.18384-18391, 2004. ,
Involvement of VDAC, Bax and ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis, PLoS One, vol.4, issue.8, p.6688, 2009. ,
Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis, Sci Rep, vol.7, issue.1, p.15552, 2017. ,
Ceramide synthases and ceramide levels are increased in breast cancer tissue, Carcinogenesis, vol.30, issue.5, pp.745-752, 2009. ,
The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1, J Cell Biochem, vol.101, issue.1, pp.259-270, 2007. ,
KEYNOTE-522: Phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo + chemo as neoadjuvant therapy followed by pembro vs placebo as adjuvant therapy for triple-negative breast cancer (TNBC), Journal of Clinical Oncology, vol.36, issue.15_suppl, pp.602-602, 2018. ,
Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses, Cancer Research, vol.77, pp.2986-2986, 2013. ,
Pembrolizumab (pembro) + chemotherapy (chemo) as neoadjuvant treatment for triple negative breast cancer (TNBC): Preliminary results from KEYNOTE-173, Journal of Clinical Oncology, vol.35, pp.556-556, 2017. ,
The use of FoxP3 as a biomarker and prognostic factor for malignant human tumors, Cancer Epidemiol Biomarkers Prev, vol.16, issue.10, pp.1931-1934, 2007. ,
Sphingosine-1-phospate receptor 4 (S1P(4)) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model, FASEB J, vol.25, issue.11, pp.4024-4036, 2011. ,
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients, Science, vol.309, issue.5741, pp.1735-1739, 2005. ,
A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer, Clin Cancer Res, vol.23, issue.15, pp.4046-4054, 2017. ,
,
Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy, Nat Chem Biol, vol.8, issue.10, pp.831-838, 2012. ,
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer, Br J Cancer, vol.109, issue.10, pp.2705-2713, 2013. ,
Fingolimod modulates peripheral effector and regulatory T cells in MS patients, J Neuroimmune Pharmacol, vol.8, issue.5, pp.1106-1113, 2013. ,
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting, Breast Cancer Res, vol.19, issue.1, p.99, 2017. ,
P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest, Cell Death Dis, vol.6, p.1947, 2015. ,
TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy, Cancer Immunol Res, vol.3, issue.5, pp.518-525, 2015. ,
Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells, J Immunol, vol.180, issue.10, pp.6452-6456, 2008. ,
Functional rafts in cell membranes, Nature, vol.387, issue.6633, pp.569-572, 1997. ,
A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition, Breast Care (Basel), vol.8, issue.2, pp.149-154, 2013. ,
Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate, J Lipid Res, vol.51, issue.9, pp.2546-2559, 2010. ,
Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis, J Biol Chem, vol.287, issue.48, pp.40198-40204, 2012. ,
The lipids C2-and C16-ceramide form large stable channels. Implications for apoptosis, J Biol Chem, vol.275, issue.49, pp.38640-38644, 2000. ,
Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations, Mitochondrion, vol.6, issue.3, pp.118-125, 2006. ,
An obligate role for membraneassociated neutral sphingomyelinase activity in orienting chemotactic migration of human neutrophils, Am J Respir Cell Mol Biol, vol.44, issue.2, pp.205-212, 2011. ,
Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells, Nat Immunol, vol.14, issue.12, pp.1285-1293, 2013. ,
Resistance of various inbred strains of mice to tumor homoiotransplants, and its relation to the H-2 allele which each carries, J Natl Cancer Inst, vol.14, issue.3, pp.485-491, 1953. ,
Ceramide synthesis regulates T cell activity and GVHD development, JCI Insight, vol.2, issue.10, 2017. ,
Tumorinfiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art, Breast, vol.35, pp.142-150, 2017. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, vol.98, pp.10869-10874, 2001. ,
Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response, Biochem J, vol.424, issue.2, pp.273-283, 2009. ,
Autoreactivity to Sulfatide by Human Invariant NKT Cells, J Immunol, vol.199, issue.1, pp.97-106, 2017. ,
Genetic and epigenetic signatures of breast cancer subtypes, Front Biosci (Elite Ed), vol.4, pp.934-949, 2012. ,
Role of caspases in CD95-induced biphasic activation of acid sphingomyelinase, Oncotarget, vol.8, issue.12, pp.20067-20085, 2017. ,
Ceramide-independent CD28 and TCR signaling but reduced IL-2 secretion in T cells of acid sphingomyelinase-deficient mice, Eur J Immunol, vol.28, issue.3, pp.874-880, 1998. ,
Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells, J Pharmacol Exp Ther, vol.307, issue.2, pp.468-475, 2003. ,
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma, Clin Cancer Res, vol.11, issue.9, pp.3465-3474, 2005. ,
Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration, FASEB J, vol.25, issue.2, pp.600-612, 2011. ,
Novel ceramide analogs as potential chemotherapeutic agents in breast cancer, J Pharmacol Exp Ther, vol.309, issue.2, pp.523-532, 2004. ,
Blocking the recruitment of naive CD4(+) T cells reverses immunosuppression in breast cancer, Cell Res, vol.27, issue.4, pp.461-482, 2017. ,
Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization, J Biol Chem, vol.277, issue.26, pp.23294-23300, 2002. ,
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1, J Cell Biol, vol.173, issue.2, pp.301-310, 2006. ,
Estrogen defines the dynamics and destination of transactivated EGF receptor in breast cancer cells: role of S1P(3) receptor and Cdc42, Exp Cell Res, vol.319, issue.4, pp.455-465, 2013. ,
Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway, Endocrinology, vol.150, issue.10, pp.4484-4492, 2009. ,
Sphingosine kinase transmits estrogen signaling in human breast cancer cells, Mol Endocrinol, vol.17, issue.10, pp.2002-2012, 2003. ,
Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells, J Clin Invest, vol.109, issue.6, pp.827-836, 2002. ,
Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis, Prog Brain Res, vol.101, issue.3, pp.482-484, 1994. ,
G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase, Cardiovasc Res, vol.79, issue.4, pp.689-697, 2008. ,
Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells, Blood, vol.102, issue.5, pp.1693-1700, 2003. ,
Regulatory T cells in cancer immunotherapy, Cell Res, vol.27, issue.1, pp.109-118, 2017. ,
Sphingomyelin synthase 2 is palmitoylated at the COOHterminal tail, which is involved in its localization in plasma membranes, Biochem Biophys Res Commun, vol.381, issue.3, pp.328-332, 2009. ,
Identification and characterization of a sphingolipid delta 4-desaturase family, J Biol Chem, vol.277, issue.28, pp.25512-25518, 2002. ,
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor, Circulation, vol.114, issue.13, pp.1403-1409, 2006. ,
Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions, Oncoimmunology, vol.5, issue.1, p.1055444, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01438254
,
The Immune Landscape of Cancer, Immunity, vol.48, issue.4, pp.812-830, 2018. ,
beta4GalT6 is involved in the synthesis of lactosylceramide with less intensity than beta4GalT5, Glycobiology, vol.23, issue.10, pp.1175-1183, 2013. ,
A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction, J Exp Med, vol.189, issue.10, pp.1581-1589, 1999. ,
Ceramide triggers budding of exosome vesicles into multivesicular endosomes, Science, vol.319, issue.5867, pp.1244-1247, 2008. ,
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development, Clin Cancer Res, vol.14, issue.11, pp.1013-1027, 2008. ,
Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy, J Immunother, vol.40, issue.8, pp.233-236, 2017. ,
,
Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient, Biochem J, vol.397, issue.3, pp.461-471, 2006. ,
Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles, J Lipid Res, vol.59, issue.8, pp.1325-1340, 2018. ,
Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines, Biochem Biophys Res Commun, vol.464, issue.3, pp.833-839, 2015. ,
Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals, J Lipid Res, vol.58, issue.6, pp.1247-1258, 2017. ,
Immunotherapy for Breast Cancer: What Are We Missing?, Clin Cancer Res, vol.23, issue.11, pp.2640-2646, 2017. ,
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor, Nat Immunol, vol.8, issue.12, pp.1337-1344, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00297257
Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration, FASEB J, vol.19, issue.12, pp.1731-1733, 2005. ,
Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling, Oncotarget, vol.7, issue.20, pp.29563-29576, 2016. ,
CD103 and Intratumoral Immune Response in Breast Cancer, Clin Cancer Res, vol.22, issue.24, pp.6290-6297, 2016. ,
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients, Am J Pathol, vol.177, issue.5, pp.2205-2215, 2010. ,
ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2, J Exp Med, vol.212, issue.2, pp.217-233, 2015. ,
Ceramide synthases CerS4 and CerS5 are upregulated by 17beta-estradiol and GPER1 via AP-1 in human breast cancer cells, Biochem Pharmacol, vol.92, issue.4, pp.577-589, 2014. ,
S1PR1 on tumorassociated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1beta, J Exp Med, vol.214, issue.9, pp.2695-2713, 2017. ,
Plasma lipid profiling in a large population-based cohort, J Lipid Res, vol.54, issue.10, pp.2898-2908, 2013. ,
Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer, Br J Cancer, vol.108, issue.1, pp.155-162, 2013. ,
College of American Pathologists Clinical Practice Guideline Focused Update Summary, J Oncol Pract, vol.14, issue.7, pp.437-441, 2018. ,
FTY720 enhances TRAILmediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells, Oncotarget, vol.6, issue.13, pp.11614-11626, 2015. ,
Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer, Clin Immunol, vol.135, issue.3, p.589, 2010. ,
C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: a mechanism study, Exp Cell Res, vol.332, issue.1, pp.47-59, 2015. ,
The domain responsible for sphingomyelin synthase (SMS) activity, Biochim Biophys Acta, vol.1781, issue.10, pp.610-617, 2008. ,
Higher densities of Foxp3(+) regulatory T cells are associated with better prognosis in triple-negative breast cancer, Breast Cancer Res Treat, vol.163, issue.1, pp.21-35, 2017. ,
Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways, Blood, vol.112, issue.4, pp.1129-1138, 2008. ,
Ceramide increases Fas-mediated apoptosis in glioblastoma cells through FLIP down-regulation, J Neurooncol, vol.60, issue.2, pp.2773-2791, 2002. ,
Sphingosine-1-phosphate reduces adhesion of malignant mammary tumor cells MDA-MB-231 to microvessel walls by protecting endothelial surface glycocalyx, Cell Mol Biol, vol.63, issue.4, pp.16-22, 2017. ,
CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer, Cancer Res, vol.75, issue.20, pp.4312-4321, 2015. ,
Ceramide Nanoliposomes as a MLKL-Dependent, Necroptosis-Inducing, Chemotherapeutic Reagent in Ovarian Cancer, Mol Cancer Ther, vol.17, issue.1, pp.50-59, 2018. ,
mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis, Cancer Res, vol.73, issue.6, pp.1946-1957, 2013. ,
Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast, Biochem Biophys Res Commun, vol.242, issue.3, pp.502-507, 1998. ,
Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development, Cell Physiol Biochem, vol.39, issue.3, pp.985-995, 2016. ,
Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer, Oncol Lett, vol.14, issue.1, pp.63-72, 2017. ,
, Annexe 4
, Stratégie d'analyses des sous-populations de TIL par cytométrie en flux Analyse par cytométrie en flux des marquages lymphocytaires avec le premier panel d'anticorps. Stratégie d'analyse du panel d'anticorps pour l'étude des lymphocytes T CD8 + . L'exclusion des doublets est réalisée sur 2 fenêtres successives avec l'aire et la largeur des paramètres non fluorescents. Les cellules mortes sont éliminées avec le marqueur de viabilité et un premier fenêtrage des lymphocytes est réalisé avec le CD45, Les lymphocytes T sont repérés avec le marqueur CD3 et les T CD4 + et CD8 + sont aussi séparée sur un autre histogramme. Les populations CD8 + naïves, CM, EM, EMRA sont séparées avec CD45RO et CCR7